Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
11/2013
11/20/2013CN103402979A Chemical compounds
11/20/2013CN103396402A Substituted aminoindanes and analogs thereof, and pharmaceutical use thereof
11/20/2013CN103396351A Pyrrolidone Bc1-2 protein small-molecule inhibitor compound, and preparation, pharmaceutical composition and pharmaceutical use thereof
11/20/2013CN102675181B Preparation method of levetiracetam
11/20/2013CN101460151B Pharmaceutical formulations: salts of 8-[{1-(3,5-bis (trifluoromethy1)pheny1)-e thoxy}-methy1]-8-pheny1-1,7-diaza-spiro[4.5] decan-2-one and treatment methods using the same
11/19/2013US8585779 Composition comprising at least one 2-pyrrolidone functionalized in the 4 position with a carboxylic acid or amide, and at least one direct dye or a pigment for dyeing keratin fibres
11/14/2013WO2013169396A1 Compounds with trpv4 activity, compositions and associated methods thereof
11/14/2013US20130303757 Polymer precursors of radiolabeled compounds, and methods of making and using the same
11/14/2013US20130303585 Small molecule rnase inhibitors and methods of use
11/14/2013US20130303547 HCV Protease Inhibitors and Uses Thereof
11/14/2013US20130303539 Compounds with trpv4 activity, compositions and associated methods thereof
11/14/2013US20130303525 Kappa opioid receptor agonists
11/14/2013US20130303506 Amino-derivatives as novel inhibitors of histone deacetylase
11/14/2013US20130299391 Compounds and methods for inhibiting corrosion in hydrocarbon processing units
11/14/2013CA2875842A1 Compounds with trpv4 activity, compositions and associated methods thereof
11/14/2013CA2873016A1 Compositions and methods for the treatment of epilepsy
11/13/2013EP2661424A1 Chemical compounds
11/13/2013EP2569263B1 A thionation process and a thionating agent
11/13/2013CN103387529A Anti-TMV (Tobacco Mosaic Virus) tripyrrole ring compound and preparation method and application thereof
11/13/2013CN103387528A Resolution method of N-methyl-2(2-hydroxyethyl)pyrrolidine and application thereof
11/13/2013CN102408286B Preparation method of N,N-disubstituted sulfonamide compound
11/13/2013CN102382027B Method for preparing levetiracetam
11/13/2013CN101868455B Therapeutic substituted lactams
11/12/2013US8580974 Processes
11/12/2013US8580973 Process for the preparation of 2,2-difluoroethylamine
11/07/2013US20130296576 High stable non-ionic n-vinyl butyrolactam iodine and preparation method thereof
11/07/2013US20130296389 Fungicide Active Substance Combinations
11/07/2013US20130296355 Glucagon receptor modulators
11/07/2013US20130296332 1h-quinazoline-2,4-diones
11/07/2013US20130296322 Serotonin reuptake inhibitors
11/07/2013US20130296279 Substituted tetracyclines
11/07/2013US20130295040 Polymer
11/06/2013CN103384659A Thioamide compound, method for producing thioamide compound, method for producing [(4r,6r)-6-aminoethyl-1,3-dioxane-4-yl]acetate derivative, and method for producing atorvastatin
11/06/2013CN103382174A Cyclopropyl amine derivatives as histamin h3 receptor modulators
11/06/2013CN102617440B Method for preparing atorvastatin calcium
11/06/2013CN102558014B Oxiracetam compound with steady crystal form
11/06/2013CN102241604B Amino acid modified curcumin, synthesis method thereof, and application thereof
11/06/2013CN102050747B Preparation method of organic onium tetrafluoroaluminate and method for preparing aluminum oxide through low temperature electrolysis
11/06/2013CN101962353B Preparation method of (R) or (S)-2-aminomethyl tetrahydropyrrole
11/06/2013CN101935285B Hexafluoroaluminate of organic onium, and preparation method and application thereof
11/06/2013CN101006052B Pyrrole derivatives as pharmaceutical agents
11/05/2013US8575363 Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitors
11/05/2013US8575208 Inhibitors of serine proteases
11/05/2013US8575197 Pyrolinone derivative and pharmaceutical composition comprising the same
11/05/2013US8575135 Antiviral compounds
11/05/2013US8574569 Stabilized protease composition
11/05/2013CA2492803C Oxime conjugates and methods for their formation and use
11/05/2013CA2481202C Functionalized ionic liquids, and methods of use thereof
10/2013
10/31/2013WO2013163454A2 Psyllid attractants and their uses
10/31/2013WO2013162390A1 Process for preparation of high purity n- [2- (diethylamine) ethyl] - 5 - formyl - 2, 4 - dimethyl - 1h - pyrrole - 3 - carboxyamide
10/31/2013WO2013161993A1 Trans-2-decenoic acid derivative and drug containing same
10/31/2013WO2013161851A1 Benzamide derivative
10/31/2013WO2013160418A1 Novel compounds
10/31/2013WO2013160273A1 (3,4-dichloro-phenyl)-((s)-3-propyl-pyrrolidin-3-yl)-methanone hydrochloride and manufacturing processes
10/31/2013WO2013159285A1 Method for preparing (s)-oxiracetam
10/31/2013WO2013159283A1 Method for preparing (s)-oxiracetam
10/31/2013US20130289284 Renewable modified natural compounds
10/31/2013US20130289249 Simplified one-pot synthesis of [18f]sfb for radiolabeling
10/31/2013US20130289075 Iap binding compounds
10/31/2013US20130289034 4-(p-QUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES
10/31/2013US20130289003 Diazeniumdiolate heterocyclic derivatives
10/31/2013US20130288331 Peptidomimetic compounds and related methods
10/31/2013US20130287727 Psyllid Attractants and Their Uses
10/30/2013EP2655399A1 Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors iia and xa
10/30/2013CN103373950A Maleimide group-containing bisphenol monomer, synthetic method and applications
10/30/2013CN103373949A Preparation method of N-phenylmaleimide (PMI)
10/30/2013CN103373948A Preparation method for natural product (-)-kainic acid
10/30/2013CN103373940A Novel process for synthesizing N-FMOC-amino acid crude product of non-active side chain
10/30/2013CN101906056B Cycloalkane amine compound as M2 inhibitor and application thereof
10/30/2013CN101432275B Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
10/29/2013US8569304 Active esters of N-substituted piperazine acetic acids, including isotopically enriched versions thereof
10/29/2013US8569267 Tetracyclic tetrahydrofuran derivatives containing cyclic amine side chain
10/29/2013US8568699 Soft anticholinergic zwitterions
10/24/2013WO2013157955A1 Geranyl geranyl acetone analogs and uses thereof
10/24/2013WO2013157926A1 Geranyl geranyl acetone analogs and uses thereof
10/24/2013US20130281453 Anti-cancer serine hydrolase inhibitory carbamates
10/24/2013US20130281452 Substituted 4-aminobenzamides as kcnq2/3 modulators
10/24/2013US20130281294 Use of sarmentine and its analogs for controlling plant pests
10/24/2013US20130280305 Cationic lipid
10/23/2013EP2651886A1 Method for depigmenting keratin materials using resorcinol derivatives
10/23/2013EP2651885A1 Anti-viral compounds
10/23/2013EP2651884A2 Process and intermediates for preparing macrolactams
10/23/2013CN103370306A Glucagon receptor modulator
10/23/2013CN103360364A Synthetic method of aromatic cyclo-ethanol
10/23/2013CN103360343A Preparation method of piperazine amide compound
10/23/2013CN103360297A Preparation method for trans-3-hydroxy-L-proline
10/23/2013CN103360296A New synthetic method of high-optical activity prolinamide
10/23/2013CN103360257A 聚合性联苯化合物 Polymerizable biphenyl compounds
10/22/2013US8563750 Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylmino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)
10/22/2013US8563736 Amide derivatives, process for preparation thereof and use thereof as insecticide
10/22/2013US8563714 Bridged spiro [2.4] heptane derivatives as ALX receptor and/or FPRL2 agonists
10/22/2013US8563596 Enantiomerically pure compounds for the treatment of proliferative disorders
10/17/2013WO2013154381A1 Method for selective cell attachment/detachment, cell patternization and cell harvesting by means of near infrared rays
10/17/2013US20130274479 Aminohydroxylation of alkenes
10/17/2013US20130274466 Process for the preparation of tetracyclic derivatives and intermediate products used in the process
10/17/2013US20130274283 Premature-termination-codons readthrough compounds
10/17/2013US20130274249 Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
10/17/2013US20130274240 Fluorene compound and pharmaceutical use thereof
10/16/2013EP2650279A2 Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use
10/16/2013EP2650274A2 A thionation process and a thionating agent
1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 ... 404